Verition Fund Management LLC Neogenomics Inc Transaction History
Verition Fund Management LLC
- $17.4 Billion
- Q3 2024
A detailed history of Verition Fund Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 15,510 shares of NEO stock, worth $218,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,510Holding current value
$218,535% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding NEO
# of Institutions
296Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$277 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$198 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$97.1 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$93 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$92.2 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.77B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...